35656-89-4

Basic information

• Product Name: 4-(4-BROMOPHENYL)BUTANOIC ACID
• Synonyms: 4-(4-BROMOPHENYL)BUTANOIC ACID;4-(4-Bromophenyl)butanic acid;4-(4-BROMOPHENYL)BUTYRIC ACID;4-broMo-Benzenebutanoic acid
• CAS NO: 35656-89-4
• Molecular Formula: C₁₀H₁₁BrO₂
• Molecular Weight: 243.1
• Product Categories: CHIRAL CHEMICALS
• Mol File: 35656-89-4.mol

Chemical Properties

• Melting Point: 67 °C
• Boiling Point: 176 °C / 3mmHg
• Flash Point: 166.11 °C
• Appearance: /
• Density: 1.464 g/cm³
• Vapor Pressure: 1.57E-05mmHg at 25°C
• Refractive Index: 1.567
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• PKA: 4.74±0.10(Predicted)
• CAS DataBase Reference: 4-(4-BROMOPHENYL)BUTANOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-BROMOPHENYL)BUTANOIC ACID(35656-89-4)
• EPA Substance Registry System: 4-(4-BROMOPHENYL)BUTANOIC ACID(35656-89-4)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 35656-89-4(Hazardous Substances Data)

Usage

Physical form

Solid

InChI:InChI=1/C10H11BrO2/c11-9-6-4-8(5-7-9)2-1-3-10(12)13/h4-7H,1-3H2,(H,12,13)

Upstream product

• 124-38-9 carbon dioxide 
• 106-37-6 1.4-dibromobenzene 
• 108-86-1 bromobenzene 
• 74532-94-8 1-bromo-4-(but-1-en-1-yl)benzene 
• 1122-91-4 4-bromo-benzaldehyde 
• 22135-53-1 1-(4'-bromophenyl)-1-butanol 
• 108-30-5 succinic acid anhydride 
• 75906-36-4 4-(p-bromophenyl)-butan-1-ol 
• 7647-01-0 hydrogenchloride 
• 6340-79-0 4-oxo-4-(4-bromophenyl)butanoic acid 
• 64-19-7 acetic acid 
• 108-88-3 toluene 

Downstream Products

• 943739-88-6 4-[4-(5,5-dimethyl-[1,3,2]dioxaborinan-2-yl)phenyl]butyric acid 
• 207989-90-0 5-(4-bromophenyl)pyrrolidin-2-one 
• 405522-18-1 (R)-5-(4-bromophenyl)pyrrolidin-2-one 
• 1315468-28-0 tert-butyl 4-(4-bromophenyl)butanoate 

Relevant articles and documents

A new charge derivatization procedure for peptide sequencing

The peptide sequencing was deduced by a latest approach of charge derivatization using mass spectrometry. The mass difference between consecutive ions within a series allows the determination of the identity of the consecutive amino acids and thus to dedu

Synthesis of Novel Pterocarpen Analogues via [3?+?2] Coupling-Elimination Cascade of α,α-Dicyanoolefins with Quinone Monoimines

By employing triethylamine as a catalyst, [3?+?2] coupling-elimination cascade of α,α-dicyanoolefins with quinone monoimines was realized. The reactions afforded various novel pterocarpen analogues with generally moderate yields (up to 75%). In addition, a plausible reaction mechanism was proposed.

Visible-light-induced oxidation/[3 + 2] cycloaddition/oxidative aromatization to construct benzo[ a]carbazoles from 1,2,3,4-tetrahydronaphthalene and arylhydrazine hydrochlorides

An efficient synthesis of benzo[a]carbazoles via visible-light-induced tandem oxidation/[3 + 2] cycloaddition/oxidative aromatization reactions was reported. The benzylic C(sp3)-H of tetrahydronaphthalene was activated through visible-light photoredox catalyst with oxygen as the clean oxidant under mild reaction conditions. This protocol proceeds efficiently with broad substrate scope, and the mechanism study was performed.

Combined Photoredox/Enzymatic C?H Benzylic Hydroxylations

Chemical transformations that install heteroatoms into C?H bonds are of significant interest because they streamline the construction of value-added small molecules. Direct C?H oxyfunctionalization, or the one step conversion of a C?H bond to a C?O bond, could be a highly enabling transformation due to the prevalence of the resulting enantioenriched alcohols in pharmaceuticals and natural products,. Here we report a single-flask photoredox/enzymatic process for direct C?H hydroxylation that proceeds with broad reactivity, chemoselectivity and enantioselectivity. This unified strategy advances general photoredox and enzymatic catalysis synergy and enables chemoenzymatic processes for powerful and selective oxidative transformations.

An Electrophilic Trifluoromethylthiolation of Silylenol Ethers and β-Naphthols with Diethylaminosulfur Trifluoride and (Trifluoromethyl)trimethylsilane

An efficient and general trifluoromethylthiolation of silylenol ethers and β-naphthols have been accomplished employing the combination of diethylaminosulfur trifluoride (DAST) and (trifluoromethyl)trimethylsilane (CF3TMS) as source of electrophilic trifluoromethylthio moiety for the synthesis of α-trifluoromethylthiolated carbonyl compounds and β-naphthols in good yields. Important features of this method include wide functional group tolerance and use of readily available DAST/CF3TMS. Potential of the methodology was demonstrated via the synthesis of α-trifluoromethylthiolated (+)-4-cholesten-3-one and naphthoquinone. (Figure presented.).

Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent

Photoremovable protecting groups added to bioactive molecules provide spatial and temporal control of the biological effects. We present synthesis and characterization of the first photoactivatable small-molecule tubulin inhibitor. By blocking the pharmacophoric OH group on compound 1 with photoremovable 4,5-dimethoxy-2-nitrobenzyl moiety we developed the photocaged prodrug 2 that had no effect in biological assays. Short UV light exposure of the derivative 2 or UV-irradiation of cells treated with 2 resulted in fast and potent inhibition of tubulin polymerization, attenuation of cell viability, and apoptotic cell death, implicating release of the parent active compound. This study validates for the first time the photoactivatable prodrug concept in the field of small molecule tubulin inhibitors. The caged derivative 2 represents a novel tool in antitubulin approaches.

ANTI-CANCER COMPOUNDS

The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).

Highly enantioselective [3+2] coupling of cyclic enamides with quinone monoimines promoted by a chiral phosphoric acid

Enantioselective [3+2] coupling of cyclic enamides with quinone monoimines was realised using a chiral phosphoric acid as a catalyst. This transformation allowed for the synthesis of highly enantioenriched polycyclic 2,3-dihydrobenzofurans (up to 99.9% ee). The absolute configuration of one product was determined by an X-ray crystal structural analysis. We also found a possible mechanism for this reaction.

INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS)

A series of phenelzine analogs comprising a phenelzine scaffold linked to an aromatic moiety and their use as inhibitors of lysine-specific demethylase 1 (LSD1) and/or one or more histone deacetylases (HDACs) is provided. The presently disclosed phenelzine analogs exhibit potency and selectivity for LSD1 versus MAO and LSD2 enzymes and exhibit bulk, as well as, gene specific histone methylation changes, anti-proliferative activity in several cancer cell lines, and neuroprotection in response to oxidative stress. Accordingly, the presently disclosed phenelzine analogs can be used to treat diseases, conditions, or disorders related to LSD1 and/or HDACs, including, but not limited to, cancers and neurodegenerative diseases.

Carboxylation of alkylboranes by N-heterocyclic carbene copper catalysts: Synthesis of carboxylic acids from terminal alkenes and carbon dioxide

Caught in the act: N-Heterocyclic carbene copper(I) complexes (1; IPr=1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene) serve as an excellent catalyst for the carboxylation of alkylboranes (2; R=alkyl) with CO2 to afford a variety of functionalized carboxylic acids (3) in high yields. A novel copper methoxide/alkylborane adduct (A) and its subsequent CO2 insertion product (B) have been isolated and shown to be true active catalyst species.